BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)

CUSIP: 09077V100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
35,863,005
Total 13F shares
23,526,757
Share change
+1,599,465
Total reported value
$312,321,217
Put/Call ratio
0%
Price per share
$13.23
Number of holders
111
Value change
+$36,760,929
Number of buys
63
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 09077V100?
CUSIP 09077V100 identifies BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) as of Q4 2025

As of 31 Dec 2025, BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,526,757 shares. The largest 10 holders included a16z Capital Management, L.L.C., Sofinnova Investments, Inc., Cormorant Asset Management, LP, Octagon Capital Advisors LP, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., ORBIMED ADVISORS LLC, Sands Capital Alternatives, LLC, and Pivotal bioVenture Partners Investment Advisor LLC. This page lists 111 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.